Rezurock — Medical Mutual

Initial criteria

• Patient is age ≥ 12 years
• Patient has chronic graft-versus-host disease
• Patient has tried at least two conventional systemic treatments for chronic graft-versus-host disease

Reauthorization criteria

• Response to therapy is required for continuation of therapy

Approval duration

365 days